Vietnam-made vaccine for lumpy skin disease enters South Korea market

The company's General Director said South Korea needs the vaccine due to recent outbreaks. AVAC's vaccine was chosen for its quality and price.
South Korea ordered the vaccine in March and wanted it by May 15.
AVAC tested its vaccine in Europe and Africa. The vaccine was also checked in a lab in Belgium.
South Korea likes AVAC's technical papers and product quality.
A professor said the export is a big step for Vietnam's veterinary vaccine research. It shows Vietnam's biotechnology level is good.
The export shows Vietnamese scientists and researchers are making good progress. The vaccine is used in Vietnam and is now going international.
The chairman of the Animal Husbandry Association said the export is a big milestone for Vietnam's veterinary vaccine industry.
When lumpy skin disease came to Vietnam, the country had to import vaccines. Now, Vietnamese companies make their own vaccines.
Exporting the vaccine to South Korea shows Vietnamese companies are getting better at making veterinary vaccines.